Author
Listed:
- Samuel J. Bunu
(Niger Delta University, Nigeria)
- Deghinmotei Alfred-Ugbenbo
(Bayelsa Medical University, Nigeria)
- Azibanasamesa D.C. Owaba
(Niger Delta University, Nigeria)
- Benita Okelekele
(Niger Delta University, Nigeria)
Abstract
The current study sought to assess the phytochemicals and antimicrobial activities of Psidium guajava Linnaeus leaves extracts. The contents of healthy free fresh leaves of Psidium guajava Linnaeus were analyzed for antibacterial efficacy using dichloromethane (DCM), palm wine, and n-hexane solvents. The presence of several chemical components was revealed by phytochemical analysis of the extracts. The Agar disc diffusion method was used to assess antibacterial activity against five clinically significant organisms. The extract's zone of inhibition against each organism was measured. The presence of phytochemicals such as tannins, terpenoids, flavonoids, alkaloids, and phenol were discovered. Saponin was not found in all of the solvents tested. The antibacterial results showed that the n-hexane fraction had 44mm as zone inhibition against Bacillus subtilis at 25 mg/ml, followed by 42 mm in Escherichia coli at the same concentration, which was significantly higher than the standard amoxicillin at 25 ug. The highest zone of inhibition for DCM fraction was at 25 mg/ml (35 mm) and 10 mg/ml (25 mm) against Pseudomonas aeruginosa and E. coli, respectively, with similar zones of inhibition to the standard. Finally, resistance was observed in P. aeruginosa, but significant inhibition was observed against B. subtilis (30mm), E. coli (15 mm), and S. aureus (15 mm) at 15%. As a result, Psidium guajava leaf extracts contain phytochemicals as well as significant antibacterial properties, particularly against B. subtilis and E. coli, and can be used to obtain useful lead compounds for the eventual synthesis of medicinally significant antioxidant and antibacterial agents.
Suggested Citation
Handle:
RePEc:epw:pharma:v:3:y:2023:i:3:id:767
DOI: 10.24018/ejpharma.2023.3.3.67
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:pharma:v:3:y:2023:i:3:id:767. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support Team (email available below). General contact details of provider: https://eu-opensci.org/index.php/pharma .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.